{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T02:23:43Z","timestamp":1788920623918,"version":"build-2803163510"},"reference-count":65,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100000038","name":"NSERC","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000038","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Psychoneuroendocrinology"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1016\/j.psyneuen.2021.105257","type":"journal-article","created":{"date-parts":[[2021,5,12]],"date-time":"2021-05-12T11:49:57Z","timestamp":1620820197000},"page":"105257","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["A ganglionic blocker and adrenoceptor ligands modify clozapine-induced insulin resistance"],"prefix":"10.1016","volume":"129","author":[{"given":"Jessica W.Y.","family":"Yuen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cathy K.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David D.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ric M.","family":"Procyshyn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William G.","family":"Panenka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William G.","family":"Honer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alasdair M.","family":"Barr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.psyneuen.2021.105257_bib1","series-title":"Beta 1 Receptors; Statpearls. Treasure Island (FL), StatPearls Publishing Copyright \u00a9 2020","author":"Alhayek","year":"2020"},{"key":"10.1016\/j.psyneuen.2021.105257_bib2","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/S0006-8993(02)03616-8","article-title":"Comparative effects of the antipsychotics sulpiride or risperidone in rats. I: bodyweight, food intake, body composition, hormones and glucose tolerance","volume":"957","author":"Baptista","year":"2002","journal-title":"Brain Res."},{"key":"10.1016\/j.psyneuen.2021.105257_bib3","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1177\/0004867415585584","article-title":"Heterogeneity of clozapine-associated myocarditis: an opportunity for novel preventing strategies","volume":"49","author":"Baptista","year":"2015","journal-title":"Aust. N. Z. J. Psychiatry"},{"key":"10.1016\/j.psyneuen.2021.105257_bib4","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.schres.2015.05.025","article-title":"Colonic transit diagnostic test shows significant gastrointestinal hypomotility in clozapine-treated patients in comparison with subjects treated with other antipsychotics","volume":"166","author":"Baptista","year":"2015","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.psyneuen.2021.105257_bib5","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.neuropharm.2006.04.004","article-title":"Iloperidone reduces sensorimotor gating deficits in pharmacological models, but not a developmental model, of disrupted prepulse inhibition in rats","volume":"51","author":"Barr","year":"2006","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.psyneuen.2021.105257_bib6","doi-asserted-by":"crossref","first-page":"S508","DOI":"10.1097\/01.CCM.0000278047.06965.20","article-title":"Glucose metabolism and catecholamines","volume":"35","author":"Barth","year":"2007","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.psyneuen.2021.105257_bib7","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1038\/oby.2002.75","article-title":"In vivo response to alpha(1)-adrenoreceptor stimulation in human white adipose tissue","volume":"10","author":"Boschmann","year":"2002","journal-title":"Obes. Res."},{"key":"10.1016\/j.psyneuen.2021.105257_bib8","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.tips.2010.07.002","article-title":"Preclinical models of antipsychotic drug-induced metabolic side effects","volume":"31","author":"Boyda","year":"2010","journal-title":"Trends Pharm. Sci."},{"key":"10.1016\/j.psyneuen.2021.105257_bib9","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1016\/j.neuropharm.2011.02.019","article-title":"Intermittent treatment with olanzapine causes sensitization of the metabolic side-effects in rats","volume":"62","author":"Boyda","year":"2012","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.psyneuen.2021.105257_bib10","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1503\/jpn.110140","article-title":"Differential effects of 3 classes of antidiabetic drugs on olanzapine-induced glucose dysregulation and insulin resistance in female rats","volume":"37","author":"Boyda","year":"2012","journal-title":"J. Psychiatry Neurosci."},{"key":"10.1016\/j.psyneuen.2021.105257_bib11","doi-asserted-by":"crossref","first-page":"53459","DOI":"10.1371\/journal.pone.0053459","article-title":"Metabolic side-effects of the novel second-generation antipsychotic drugs asenapine and iloperidone: a comparison with olanzapine","volume":"8","author":"Boyda","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.psyneuen.2021.105257_bib12","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1111\/jne.12002","article-title":"Peripheral adrenoceptors: the impetus behind glucose dysregulation and insulin resistance","volume":"25","author":"Boyda","year":"2013","journal-title":"J. Neuroendocr."},{"key":"10.1016\/j.psyneuen.2021.105257_bib13","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1017\/S1461145713000795","article-title":"Routine exercise ameliorates the metabolic side-effects of treatment with the atypical antipsychotic drug olanzapine in rats","volume":"17","author":"Boyda","year":"2014","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.psyneuen.2021.105257_bib14","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2020.617428","article-title":"Differential effects of acute treatment with antipsychotic drugs on peripheral catecholamines","volume":"11","author":"Boyda","year":"2020","journal-title":"Front. Psychiatry"},{"key":"10.1016\/j.psyneuen.2021.105257_bib15","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/S0893-133X(97)00073-0","article-title":"Effects of clozapine on plasma catecholamines and relation to treatment response in schizophrenia: a within-subject comparison with haloperidol","volume":"17","author":"Brown","year":"1997","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.psyneuen.2021.105257_bib16","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1124\/jpet.118.248393","article-title":"Aicar prevents acute olanzapine-induced disturbances in glucose homeostasis","volume":"365","author":"Bush","year":"2018","journal-title":"J. Pharm. Exp. Ther."},{"key":"10.1016\/j.psyneuen.2021.105257_bib17","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s11892-018-1069-2","article-title":"Autonomic regulation of glucose homeostasis: a specific role for sympathetic nervous system activation","volume":"18","author":"Carnagarin","year":"2018","journal-title":"Curr. Diabetes Rep."},{"key":"10.1016\/j.psyneuen.2021.105257_bib18","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.schres.2009.05.007","article-title":"Extended release metformin for metabolic control assistance during prolonged clozapine administration: a 14 week, double-blind, parallel group, placebo-controlled study","volume":"113","author":"Carrizo","year":"2009","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.psyneuen.2021.105257_bib19","doi-asserted-by":"crossref","first-page":"3280","DOI":"10.2174\/1381612821666150619092903","article-title":"Off-label prescribing of antipsychotics in adults, children and elderly individuals: a systematic review of recent prescription trends","volume":"21","author":"Carton","year":"2015","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.psyneuen.2021.105257_bib20","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.psyneuen.2017.05.005","article-title":"Glucagon receptor knockout mice are protected against acute olanzapine-induced hyperglycemia","volume":"82","author":"Castellani","year":"2017","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.psyneuen.2021.105257_bib21","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.schres.2008.12.012","article-title":"Insulin resistance and secretion in vivo: effects of different antipsychotics in an animal model","volume":"108","author":"Chintoh","year":"2009","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.psyneuen.2021.105257_bib22","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1192\/S0007125000296840","article-title":"General pharmacology of clozapine","author":"Coward","year":"1992","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.psyneuen.2021.105257_bib23","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s00213-011-2555-2","article-title":"Gender-dependent consequences of chronic olanzapine in the rat: effects on body weight, inflammatory, metabolic and microbiota parameters","volume":"221","author":"Davey","year":"2012","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.psyneuen.2021.105257_bib24","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1038\/nrendo.2011.156","article-title":"Metabolic and cardiovascular adverse effects associated with antipsychotic drugs","volume":"8","author":"De Hert","year":"2011","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.psyneuen.2021.105257_bib25","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0893-133X(98)00047-5","article-title":"Mechanism of peripheral noradrenergic stimulation by clozapine","volume":"20","author":"Elman","year":"1999","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.psyneuen.2021.105257_bib26","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.genhosppsych.2017.06.007","article-title":"Mild to moderate clozapine-induced gastrointestinal hypomotility should not require cessation of clozapine","volume":"48","author":"Every-Palmer","year":"2017","journal-title":"Gen. Hosp. Psychiatry"},{"key":"10.1016\/j.psyneuen.2021.105257_bib27","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1111\/j.1742-7843.2011.00699.x","article-title":"Alpha2-adrenoceptor regulation of blood glucose homeostasis","volume":"108","author":"Fagerholm","year":"2011","journal-title":"Basic Clin. Pharm. Toxicol."},{"key":"10.1016\/j.psyneuen.2021.105257_bib28","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1017\/S146114571100201X","article-title":"A systematic review of the evidence of clozapine\u2019s anti-aggressive effects","volume":"15","author":"Frogley","year":"2012","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.psyneuen.2021.105257_bib29","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/0165-1781(93)90016-A","article-title":"Clozapine response and plasma catecholamines and their metabolites","volume":"46","author":"Green","year":"1993","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.psyneuen.2021.105257_bib30","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.schres.2013.02.023","article-title":"Atypical antipsychotics and effects of adrenergic and serotonergic receptor binding on insulin secretion in-vivo: an animal model","volume":"146","author":"Guenette","year":"2013","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.psyneuen.2021.105257_bib31","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1046\/j.1365-201X.2003.01162.x","article-title":"The role of intramuscular lipid in insulin resistance","volume":"178","author":"Hegarty","year":"2003","journal-title":"Acta Physiol. Scand."},{"key":"10.1016\/j.psyneuen.2021.105257_bib32","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1176\/appi.ajp.157.6.975","article-title":"Clozapine, diabetes mellitus, weight gain, and lipid abnormalities: a five-year naturalistic study","volume":"157","author":"Henderson","year":"2000","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.psyneuen.2021.105257_bib33","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/j.1471-4159.2007.04688.x","article-title":"Electroconvulsive shock treatment differentially modulates cortical and subcortical endocannabinoid activity","volume":"103","author":"Hill","year":"2007","journal-title":"J. Neurochem."},{"key":"10.1016\/j.psyneuen.2021.105257_bib34","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/sj.npp.1301209","article-title":"Acute effects of atypical antipsychotics on whole-body insulin resistance in rats: implications for adverse metabolic effects","volume":"32","author":"Houseknecht","year":"2007","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.psyneuen.2021.105257_bib35","doi-asserted-by":"crossref","first-page":"6366","DOI":"10.1016\/S0021-9258(19)84571-4","article-title":"In vivo glucose metabolism in individual tissues of the rat. Interaction between epinephrine and insulin","volume":"261","author":"James","year":"1986","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.psyneuen.2021.105257_bib36","doi-asserted-by":"crossref","first-page":"216","DOI":"10.2337\/diab.36.2.216","article-title":"Studies of midaglizole (dg-5128). A new type of oral hypoglycemic drug in healthy subjects","volume":"36","author":"Kawazu","year":"1987","journal-title":"Diabetes"},{"key":"10.1016\/j.psyneuen.2021.105257_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.psyneuen.2019.104400","article-title":"Direct effects of antipsychotic drugs on insulin, energy sensing and inflammatory pathways in hypothalamic mouse neurons","volume":"109","author":"Kowalchuk","year":"2019","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.psyneuen.2021.105257_bib38","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1093\/bmb\/ldv017","article-title":"Antipsychotic medication in schizophrenia: a review","volume":"114","author":"Lally","year":"2015","journal-title":"Br. Med. Bull."},{"key":"10.1016\/j.psyneuen.2021.105257_bib39","article-title":"Antipsychotic prescribing patterns on admission to and at discharge from a tertiary care program for treatment-resistant psychosis","volume":"13","author":"Lee","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.psyneuen.2021.105257_bib40","series-title":"Glucagon II","first-page":"537","article-title":"Glucagon and catecholamines","author":"Lefebvre","year":"1983"},{"key":"10.1016\/j.psyneuen.2021.105257_bib41","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1007\/s00213-020-05524-w","article-title":"Metformin attenuates antipsychotic-induced metabolic dysfunctions in mk801-induced schizophrenia-like rats","volume":"237","author":"Luo","year":"2020","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.psyneuen.2021.105257_bib42","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1097\/HJH.0b013e328048d004","article-title":"The sympathetic nervous system and the metabolic syndrome","volume":"25","author":"Mancia","year":"2007","journal-title":"J. Hypertens."},{"key":"10.1016\/j.psyneuen.2021.105257_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.psyneuen.2019.104413","article-title":"Female mice are protected against acute olanzapine-induced hyperglycemia","volume":"110","author":"Medak","year":"2019","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.psyneuen.2021.105257_bib44","doi-asserted-by":"crossref","first-page":"134","DOI":"10.3371\/CSRP.6.3.5","article-title":"Clozapine: balancing safety with superior antipsychotic efficacy","volume":"6","author":"Meltzer","year":"2012","journal-title":"Clin. Schizophr. Relat. Psychoses"},{"key":"10.1016\/j.psyneuen.2021.105257_bib45","doi-asserted-by":"crossref","first-page":"17450","DOI":"10.1073\/pnas.1410530111","article-title":"Catecholamine-induced lipolysis causes mtor complex dissociation and inhibits glucose uptake in adipocytes","volume":"111","author":"Mullins","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.psyneuen.2021.105257_bib46","doi-asserted-by":"crossref","first-page":"74","DOI":"10.3109\/07435800.2010.539993","article-title":"\u0392-adrenergic responsive induction of insulin resistance in liver of aging rats","volume":"36","author":"Muscogiuri","year":"2011","journal-title":"Endocr. Res."},{"key":"10.1016\/j.psyneuen.2021.105257_bib47","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1248\/bpb.b15-00842","article-title":"Mechanism underlying induction of hyperglycemia in rats by single administration of olanzapine","volume":"39","author":"Nagata","year":"2016","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.psyneuen.2021.105257_bib48","first-page":"E57","article-title":"Effects of acute alpha 2-blockade on insulin action and secretion in humans","volume":"274","author":"Natali","year":"1998","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.psyneuen.2021.105257_bib49","doi-asserted-by":"crossref","first-page":"168","DOI":"10.3371\/CSRP.KNMG.111717","article-title":"Clozapine, diabetes mellitus, cardiovascular risk and mortality: Results of a 21-year naturalistic study in patients with schizophrenia and schizoaffective disorder","volume":"12","author":"Nemani","year":"2019","journal-title":"Clin. Schizophr. Relat. Psychoses"},{"key":"10.1016\/j.psyneuen.2021.105257_bib50","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1177\/0706743717720448","article-title":"Guidelines for the pharmacotherapy of schizophrenia in adults","volume":"62","author":"Remington","year":"2017","journal-title":"Can. J. Psychiatry"},{"key":"10.1016\/j.psyneuen.2021.105257_bib51","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1093\/schbul\/sbn104","article-title":"Differential effects of various typical and atypical antipsychotics on plasma glucose and insulin levels in the mouse: evidence for the involvement of sympathetic regulation","volume":"36","author":"Savoy","year":"2010","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.psyneuen.2021.105257_bib52","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/0006-8993(93)91535-Z","article-title":"Occupancy of central neurotransmitter receptors by risperidone, clozapine and haloperidol, measured ex vivo by quantitative autoradiography","volume":"631","author":"Schotte","year":"1993","journal-title":"Brain Res."},{"key":"10.1016\/j.psyneuen.2021.105257_bib53","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1007\/BF01273320","article-title":"Blood biogenic amines during clozapine treatment of early-onset schizophrenia","volume":"104","author":"Schulz","year":"1997","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.psyneuen.2021.105257_bib54","doi-asserted-by":"crossref","first-page":"261","DOI":"10.3109\/10799893.2015.1091475","article-title":"\u03911a-adrenergic receptor prevents cardiac ischemic damage through pkc\u03b4\/glut1\/4-mediated glucose uptake","volume":"36","author":"Shi","year":"2016","journal-title":"J. Recept. Signal Transduct. Res."},{"key":"10.1016\/j.psyneuen.2021.105257_bib55","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.4088\/JCP.08r04392","article-title":"Are weight gain and metabolic side effects of atypical antipsychotics dose dependent? A literature review","volume":"70","author":"Simon","year":"2009","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.psyneuen.2021.105257_bib56","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/j.2040-4603.2015.tb00599.x","article-title":"Peripheral and central effects of circulating catecholamines","volume":"5","author":"Tank","year":"2015","journal-title":"Compr. Physiol."},{"key":"10.1016\/j.psyneuen.2021.105257_bib57","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1097\/YIC.0000000000000014","article-title":"Pharmacological treatment of antipsychotic-induced dyslipidemia and hypertension","volume":"29","author":"Tse","year":"2014","journal-title":"Int. Clin. Psychopharmacol."},{"key":"10.1016\/j.psyneuen.2021.105257_bib58","doi-asserted-by":"crossref","first-page":"I67","DOI":"10.1161\/01.HYP.19.1_Suppl.I67","article-title":"Obesity, the sympathetic nervous system, and essential hypertension","volume":"19","author":"Tuck","year":"1992","journal-title":"Hypertension"},{"key":"10.1016\/j.psyneuen.2021.105257_bib59","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/S0026-895X(25)09012-1","article-title":"Influence of age on the beta 1- and beta 2-adrenergic receptors in rat liver","volume":"42","author":"Van Ermen","year":"1992","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.psyneuen.2021.105257_bib60","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.schres.2009.09.034","article-title":"Sensitivity of the female rat to olanzapine-induced weight gain--far from the clinic?","volume":"116","author":"Weston-Green","year":"2010","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.psyneuen.2021.105257_bib61","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s00228-015-1807-1","article-title":"Treatment of clozapine-associated weight gain: a systematic review","volume":"71","author":"Whitney","year":"2015","journal-title":"Eur. J. Clin. Pharm."},{"key":"10.1016\/j.psyneuen.2021.105257_bib62","article-title":"An evaluation of the effects of the novel antipsychotic drug lurasidone on glucose tolerance and insulin resistance: a comparison with olanzapine","volume":"9","author":"Wu","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.psyneuen.2021.105257_bib63","doi-asserted-by":"crossref","first-page":"203","DOI":"10.3389\/fnins.2018.00203","article-title":"Clozapine-induced cardiovascular side effects and autonomic dysfunction: a systematic review","volume":"12","author":"Yuen","year":"2018","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.psyneuen.2021.105257_bib64","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2019.107717","article-title":"A comparison of the effects of clozapine and its metabolite norclozapine on metabolic dysregulation in rodent models","volume":"175","author":"Yuen","year":"2020","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.psyneuen.2021.105257_bib65","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.609240","article-title":"A focused review of the metabolic side-effects of clozapine","volume":"12","author":"Yuen","year":"2021","journal-title":"Front. Endocrinol."}],"container-title":["Psychoneuroendocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306453021001311?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306453021001311?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T17:14:11Z","timestamp":1759684451000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306453021001311"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":65,"alternative-id":["S0306453021001311"],"URL":"https:\/\/doi.org\/10.1016\/j.psyneuen.2021.105257","relation":{},"ISSN":["0306-4530"],"issn-type":[{"value":"0306-4530","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A ganglionic blocker and adrenoceptor ligands modify clozapine-induced insulin resistance","name":"articletitle","label":"Article Title"},{"value":"Psychoneuroendocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.psyneuen.2021.105257","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"105257"}}